Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 227

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Molecular mechanisms underlying bile acid‐stimulated glucagon‐like peptide‐1 secretion

Open access
Parker, HE, Wallis, K, le Roux, CW, Wong, KY, Reimann, F, Gribble, FM·2012·British Journal of Pharmacology

Abstract

BACKGROUND AND PURPOSE The glucagon‐like peptides GLP‐1 and GLP‐2 are secreted from enteroendocrine L‐cells following nutrient ingestion. Drugs that increase activity of the GLP‐1 axis are highly successful therapies for type 2 diabetes, and boosting L‐cell secretion is a potential strategy for future diabetes treatment. The aim of the present study was to further our understanding of the bile acid receptor GPBA (TGR5), an L‐cell target currently under therapeutic exploration. EXPERIMENTAL APPROACH GLUTag cells and mixed primary murine intestinal cultures were exposed to bile acids and a specific agonist, GPBAR‐A. Secretion was measured using hormone assays and intracellular calcium and cAMP responses were monitored using real‐time imaging techniques. KEY RESULTS Bile acid‐triggered GLP‐1 secretion from GLUTag cells was GPBA‐dependent, as demonstrated by its abolition following tgr5 siRNA transfection. Bile acids and GPBAR‐A increased GLP‐1 secretion from intestinal cultures, with evidence for synergy between the effects of glucose and GPBA activation. Elevation of cAMP was observed following GPBA activation in individual GLUTag cells. Direct calcium responses to GPBAR‐A were small, but in the presence of the agonist, a subpopulation of cells that was previously poorly glucose‐responsive exhibited robust glucose responses. In vivo , increased delivery of bile to more distal regions of the ileum augmented L‐cell stimulation. CONCLUSIONS AND IMPLICATIONS GPBA signalling in L‐cells involves rapid elevation of cAMP, and enhanced calcium and secretory responses to glucose. Modulation of this receptor therapeutically may be an attractive strategy to enhance GLP‐1 secretion and achieve better glycaemic control in diabetic patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2011.01561.x

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 227

Metadata

Authors
Parker, H., Wallis, K., le Roux, C., Wong, K., Reimann, F., & Gribble, F.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2011-12-16
Volume
165
Issue
2
Pages
414-423
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1531888366
Cited by
227
References
11
FWCI
12.47
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular mechanisms underlying bile acid‐stimulated glucagon‐like peptide‐1 secretion. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01561.x
The paper
Parker, H., Wallis, K., le Roux, C., Wong, K., Reimann, F., & Gribble, F. (2012). Molecular mechanisms underlying bile acid‐stimulated glucagon‐like peptide‐1 secretion. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01561.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.